West Pharmaceutical Services, Inc. logo
WSTWest Pharmaceutical Services, Inc.

Price History:60.26%(TTM)

Over the latest trailing 12-month period, price cagr is +60.26%. The comparable SPY value is +19.16%. Year-to-date price return is +26.94%. Price CAGR uses adjusted close price history and excludes dividends.

Current Price

$350.85

+$4.29 (+1.24%)

Previous Close: $346.56

Last Session

Open
$345.36
Day High
$351.35
Day Low
$342.70
Volume
1.23M
Avg Volume
839.43K

52-Week Position

99%

of the 52-week price range

From 52-week high
-0.41%
From 52-week low
+69.66%

52-Week Price Range

52-Week Low

$206.80

Jul 21, 2025

Current Price

$350.85

99% of range

52-Week High

$352.31

Jun 26, 2026

Low (+69.66% from current)(-0.41% from current) High

Price Returns by Period

1 Day

+1.24%

7 Days

+6.98%

30 Days

+9.03%

YTD

+26.94%

1 Year

+60.30%

vs 52W High

-0.41%

WST Price Chart

End-of-day pricesAdvanced chart →
WST$350.85 60.30%(1Y)as of Jun 26, 2026

Long-Term Performance (CAGR)

Price CAGR (3Y)

-1.32%

Price CAGR (5Y)

-0.52%

Total Return CAGR (3Y)

-1.04%

Total Return CAGR (5Y)

-0.26%

CAGR (Compound Annual Growth Rate) shows the annualized return over the specified period. Total Return includes dividends reinvested.

Key Price Statistics

Current Price$350.85
Previous Close$346.56
Day Range$342.70 - $351.35
52-Week Range$206.80 - $352.31
Volume1.23M
Average Volume839.43K
Market Cap$24.79B
% from 52W High-0.41%
Data as of Saturday, June 27, 2026

About West Pharmaceutical Services, Inc.

West Pharmaceutical Services, Inc. (WST) specializes in the development, manufacturing, and global distribution of essential containment and delivery solutions for injectable pharmaceuticals and other healthcare products. The company's operations span across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region, structured into two primary business units: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers a comprehensive array of components for injectable packaging, including stoppers and seals, alongside syringe and cartridge parts, which can be customized for specific injectable drug delivery requirements. It also provides advanced drug administration systems designed to enhance safe and effective delivery through sophisticated reconstitution, mixing, and transfer technologies. This segment further supplies ancillary services such as specialized films, protective coatings, cleaning, precision vision inspection, and sterilization processes to elevate the quality of packaging components. Innovative drug containment options, like Crystal Zenith – a cyclic olefin polymer used in vials, syringes, and cartridges – and user-friendly self-injection devices are also key offerings. Additionally, it provides a suite of integrated support services covering analytical laboratory analysis, primary packaging assistance during the pre-approval stage, engineering development, regulatory guidance, and post-purchase technical support. Its clientele primarily includes manufacturers of biologic, generic, and other pharmaceutical products. In contrast, the Contract-Manufactured Products division focuses on the design, production, and automated assembly of various devices for surgical, diagnostic, ophthalmic, and general drug delivery applications, alongside consumer items. This segment caters to pharmaceutical, diagnostic, and medical device manufacturers. The company's offerings reach customers worldwide through a dedicated sales team, an extensive distribution network, and partnerships with contract sales agents and regional distributors. Established in 1923, West Pharmaceutical Services, Inc. is headquartered in Exton, Pennsylvania.

Exton, PA
10,600 employees
Healthcare / Medical - Instruments & Supplies
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Eric Green